(Unlearned) lessons from John Graunt and Kenneth Rothman: A "CLASSic" example
Պահպանված է:
| Հրատարակված է: | Clinical Therapeutics vol. 25, no. 11 (Nov 2003), p. 2891 |
|---|---|
| Հիմնական հեղինակ: | |
| Համատեղ հեղինակ: | |
| Այլ հեղինակներ: | |
| Հրապարակվել է: |
Elsevier Limited
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | Citation/Abstract Full Text Full Text - PDF |
| Ցուցիչներ: |
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
| Համառոտագրություն: | This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Lonngterm Arthritis Safety Study. This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Long-term Arthritis Safety Study. |
|---|---|
| ISSN: | 0149-2918 1879-114X |
| DOI: | 10.1016/S0149-2918(03)80341-7 |
| Աղբյուր: | Healthcare Administration Database |